Related Funds
Funds with similar focus
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
ArriVent Biopharma | $155M | 29 Dec 2022 | Pennsylvania Furnace, Pennsylvania, United States | ||
Walking Fish Therapeutics | $23M | 16 Feb 2022 | San Francisco, California, United States | ||
ShouTi | $100M | 20 Oct 2021 | Shanghai, China | ||
Senda Biosciences | $98M | 10 Jun 2021 | Cambridge, Massachusetts, United States | ||
Arcellx | $115M | 13 Apr 2021 | Maryland, United States | ||
RNAimmune | $2M | 24 Aug 2020 | Maryland, United States | ||
Erasca | $200M | 27 Apr 2020 | San Diego, California, United States | ||
Immunocore | $130M | 02 Mar 2020 | England | ||
$75M | 18 Jun 2019 | Maryland, United States |
– ShouTi Inc. announced the close of a $100m Series B financing round.
– The round was led by BVF Partners. Additional new investors include Casdin Capital, Cormorant Asset Management, Janus Henderson Investors, Lilly Asia Ventures, Monashee Capital, Sage Partners, Stork Capital, Surveyor Capital (a Citadel company), TCG X, Terra Magnum Capital Partners, Woodline Partners, and co-founder and strategic partner Schrödinger.
– Existing investors also participated in the financing, including Eight Roads, F-Prime Capital Partners, Qiming Venture Partners, Sequoia Capital China, TF Capital and Wuxi AppTec.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
ArriVent Biopharma | $155M | 29 Dec 2022 | Pennsylvania Furnace, Pennsylvania, United States | ||
Walking Fish Therapeutics | $23M | 16 Feb 2022 | San Francisco, California, United States | ||
ShouTi | $100M | 20 Oct 2021 | Shanghai, China | ||
Senda Biosciences | $98M | 10 Jun 2021 | Cambridge, Massachusetts, United States | ||
Arcellx | $115M | 13 Apr 2021 | Maryland, United States | ||
RNAimmune | $2M | 24 Aug 2020 | Maryland, United States | ||
Erasca | $200M | 27 Apr 2020 | San Diego, California, United States | ||
Immunocore | $130M | 02 Mar 2020 | England | ||
$75M | 18 Jun 2019 | Maryland, United States |